[1] 张复春, 胡凤玉. 新型甲型H1N1流感研究进展[J]. 中山大学学报(医学科学版), 2009, 30(5): 481-485.
[2] JA Cordova-Villalobos, et al.The 2009 pandemic in Mexico: Experience and lessons regarding national preparedness policies for seasonal and epidemic influenza[J]. Gac Med Mex, 2017, 153:102-110.
[3] Zhu H, Lee ACY, Li C, et al.Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017[J]. Emerg Microbes Infect, 2018, 7(1):23.
[4] Qi W, Jia W, Liu D, et al.Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor[J]. J Virol, 2018, 92(2):e00917-e00921.
[5] 中国疾病预防控制中心. 我国从人感染病例中发现H7N9病毒变异株[EB/OL]. http://www.chinacdc.cn/yw_9324/201702/t20170219_138185.html.
[6] Ke C, Mok CKP, Zhu W, et al.Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China[J]. Emerg Infect Dis, 2017, 23(8):1332-1340.
[7] Imai M, Watanabe T, Kiso M, Nakajima N, et al.Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets[J]. Cell Host Microbe, 2017, 22(5):615-626.
[8] Shi J, Deng G, Kong H, et al.H7N9 virulent mutants detected in chickens in China pose an increased threat to humans[J]. Cell Res, 2017, 27(12):1409-1421.
[9] AC, Lowen. Constraints, Drivers, and Implications of Influenza A Virus Reassortment[J]. Annu Rev Virol, 2017, 4:105-121.
[10] Mi Liu, Xiang Zhao, Sha Hua, et al.Antigenic Patterns and Evolution of the Human Influenza A (H1N1) Virus[J]. Sci Rep, 2015, 5:14171.
[11] Bagchi S.India tackles H1N1 influenza outbreak[J]. Lancet, 2015, 385(9972):e21.
[12] 中国国家卫生计生委疾病预防控制局. 2017年全国法定传染病疫情概况[EB/OL].http://www.moh.gov.cn/jkj/s3578/201802/de926bdb046749abb7b0a8e23d929104.shtml.
[13] 中国疾病预防控制中心. 近期我国季节性流感情况与防控知识问答[EB/OL]. http://www.chinacdc.cn/jkzt/crb/bl/lxxgm/cswd/201801/t20180108_158017.html.
[14] Dayan Wang, Lei Yang, Wenfei Zhu, et al.Two Outbreak Sources of Influenza A (H7N9) Viruses Have Been Established in China[J]. J Virol, 2016, 90(12):5561-5573.
[15] Ke C, Lu J, Wu J, et al.Circulation of reassortant influenza A(H7N9) viruses in poultry and humans, GuangdongProvince, China, 2013[J]. Emerg Infect Dis, 2014, 20(12):2034-2040.
[16] Bao CJ, Cui LB, Zhou MH, Hong L, Gao GF, Wang H.Live animal markets and influenza A (H7N9) virus infection[J]. N Engl J Med, 2013, 368:2337-2339.
[17] Influenza at the human-animal interface: summary and assessment, 26 January to 2 March 2018[EB/OL]. http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_02_03_2018.pdf?ua=1.
[18] Wang X, Jiang H, Wu P, et al.Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-2017: an epidemiological study of laboratory-confirmed case series[J]. Lancet Infect Dis, 2017, 17(8):822-832.
[19] Yu H, Huang J, Huai Y, et al.The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010-2012[J]. Influenza Other Respir Viruses, 2014, 8(1):53-65.
[20] Du X, King AA, Woods RJ, Pascual M.Evolution-informed forecasting of seasonal influenza A (H3N2)[J]. Sci Transl Med, 2017, 9(413):e5325.
[21] Budd AP, Wentworth DE, Blanton L, et al.Update: Influenza Activity - United States, October 1, 2017 - February 3, 2018[J]. MMWR Morb Mortal Wkly Rep, 2018, 67(6):169-179.
[22] WHO. CDC protocol of realtime RTPCR for influenza A (H1N1) CDC protocol of realtime RTPCR for influenza A (H1N1)[EB/OL]. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/.
[23] Yang ZF, Mok CK, Liu XQ, et al.Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong province[J]. PLoS One, 2015, 10(2):e0117846
[24] 中华人民共和国国家卫生和计划生育委员会. 流行性感冒诊疗方案(2018年版)[EB/OL]. http://www.nhfpc.gov.cn/yzygj/s3594q/201801/5737c258bb0c4a0493cb4f65fcf11be1.shtml.
[25] 中华人民共和国卫生部. 甲型H1N1流感诊疗方案(2010年版)[J]. 国际呼吸杂志, 2011, 31(2): 81-84.
[26] 中华人民共和国国家卫生和计划生育委员会. 人感染H7N9禽流感诊疗方案(2017年第一版)[J]. 中华临床感染病杂志, 2017, 10(1):1-4.
[27] 中华人民共和国国家卫生和计划生育委员会. 人感染H7N9禽流感早诊早治专家共识[EB/OL]. http://www.nhfpc.gov.cn/yzygj/s3594q/201703/105e23a233f042f787e33bcf13231c03.shtml.
[28] Zheng S, Tang L, Gao H, et al.Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus[J]. Clin Infect Dis, 2018, 66(7):1054-1060.
[29] 中华医学会呼吸病学分会,中华医学会儿科学分会.流行性感冒抗病毒药物治疗与预防应用中国专家共识[J].中华医学杂志,2016,96(2):85-90.
[30] Zhang Y, Gao H, Liang W, Tang L, et al.Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study[J]. BMC Infect Dis, 2016, 16:76.
[31] Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec, 2009, 84(44):453-459.
[32] Jin J, Chen Y, Wang D, et al.The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity[J]. Arch Pharm Res, 2018, 23: 1-13.
[33] Jin J, Chen S, Wang D, et al.Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs[J]. Biomed Pharmacother, 2018, 97:385-394.
[34] Delaney JW, Pinto R, Long J, Lamontagne F, et al.The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness[J]. Crit Care. 2016, 20:75.
[35] Cao B, Gao H, Zhou B, Deng X, et al.Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia[J]. Crit Care Med, 2016, 44(6):e318-e328.
[36] Guo J, Huang F, Liu J.The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes[J]. Sci Rep, 2015 , 1(5): 10942.
[37] Wang Z, Zhu L, Nguyen THO, et al.Clonally diverse CD38(+)HLA-DR(+)CD8(+) T cells persist during fatal H7N9 disease[J]. Nat Commun, 2018, 9(1): 824.
[38] Li H, Weng H, Lan C, Zhang H, Wang X, Pan J, Chen L, Huang J.Comparison of patients with avian influenza A (H7N9) and influenza A (H1N1) complicated by acute respiratory distress syndrome[J]. Medicine (Baltimore), 2018, 97(12):e0194.
[39] Xie H, Zhou ZG, Jin W, Yuan CB, Du J, Lu J, Wang RL.Ventilator management for acute respiratory distress syndrome associated with avian influenza A (H7N9) virus infection: A case series[J]. World J Emerg Med, 2018, 9(2):118-124.
[40] Huang L, Zhang W, Yang Y, et al.Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration[J]. BMC Infect Dis, 2018, 18(1):23.
[41] Rondy M, El Omeiri N, Thompson MG, et al.Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies[J]. J Infect, 2017, 75(5):381-394.
[42] 中国疾病预防控制中心. 近期我国季节性流行情况与防控知识问答[EB/OL]. http://www.chinacdc.cn/jkzt/crb/bl/lxxgm/cswd/201801/t20180108_158017.html. |
